These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28905434)

  • 1. Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus.
    Hosomura N; Malmasi S; Timerman D; Lei VJ; Zhang H; Chang L; Turchin A
    Diabet Med; 2017 Nov; 34(11):1599-1602. PubMed ID: 28905434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study.
    Campbell MD; Babic D; Bolcina U; Smirčić-Duvnjak L; Tankova T; Mitrakou A; Kempler P; Janez A
    Acta Diabetol; 2019 Sep; 56(9):1045-1049. PubMed ID: 30993528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and consequences of declining insulin therapy by individuals with type 2 diabetes.
    Turchin A; Hosomura N; Zhang H; Malmasi S; Shubina M
    Diabet Med; 2020 May; 37(5):814-821. PubMed ID: 32077139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of glycemic control after decline of insulin therapy by patients with type 2 diabetes.
    Florez L; Shubina M; Turchin A
    J Diabetes Complications; 2019 Nov; 33(11):107418. PubMed ID: 31477552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What primary care physicians think about insulin initiation in type 2 diabetes: a field-based study.
    Ak M; Sucakli MH; Canbal M; Koşar Y
    Turk J Med Sci; 2015; 45(2):409-15. PubMed ID: 26084135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of a decision-support electronic health record system and its impact on diabetes care goals in South Asia: a mixed-methods evaluation of the CARRS trial.
    Singh K; Johnson L; Devarajan R; Shivashankar R; Sharma P; Kondal D; Ajay VS; Narayan KMV; Prabhakaran D; Ali MK; Tandon N
    Diabet Med; 2018 Dec; 35(12):1644-1654. PubMed ID: 30142228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research.
    Escalada J; Orozco-Beltran D; Morillas C; Alvarez-Guisasola F; Gomez-Peralta F; Mata-Cases M; Palomares R; Iglesias R; Carratalá-Munuera C
    Diabetes Res Clin Pract; 2016 Dec; 122():46-53. PubMed ID: 27810685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes.
    Mor A; Berencsi K; Svensson E; Rungby J; Nielsen JS; Friborg S; Brandslund I; Christiansen JS; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabet Med; 2015 Dec; 32(12):1546-54. PubMed ID: 26032247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient Psychiatric Documentation Use by Primary Care Physicians Following De-Sensitization in the Electronic Medical Record.
    Bhe E; Summers S; Pakyurek M; Soulier M; Ferranti J
    Acad Psychiatry; 2015 Dec; 39(6):639-44. PubMed ID: 25069956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IMPROVE study--a multinational, observational study in type 2 diabetes: data from the Polish cohort.
    Gumprecht J; Zurawska G; Wolnik B; Dzida G
    Endokrynol Pol; 2008; 59(6):460-6. PubMed ID: 19347809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Health Record Logs Indicate That Physicians Split Time Evenly Between Seeing Patients And Desktop Medicine.
    Tai-Seale M; Olson CW; Li J; Chan AS; Morikawa C; Durbin M; Wang W; Luft HS
    Health Aff (Millwood); 2017 Apr; 36(4):655-662. PubMed ID: 28373331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin initiation and management in people with Type 2 diabetes in an ethnically diverse population: the healthcare provider perspective.
    Patel N; Stone MA; Chauhan A; Davies MJ; Khunti K
    Diabet Med; 2012 Oct; 29(10):1311-6. PubMed ID: 22486745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
    Reach G; Pechtner V; Gentilella R; Corcos A; Ceriello A
    Diabetes Metab; 2017 Dec; 43(6):501-511. PubMed ID: 28754263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
    Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
    Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inercia clínica en el tratamiento con insulina en el primer nivel de atención.
    Vázquez F; Lavielle P; Gómez-Díaz R; Wacher N
    Gac Med Mex; 2019; 155(2):156-161. PubMed ID: 31056606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
    Davies M; Evans R; Storms F; Gomis R; Khunti K
    Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.
    Balkau B; Halimi S; Blickle JF; Vergès B; Avignon A; Attali C; Chartier I; Amelineau E
    Ann Endocrinol (Paris); 2016 Dec; 77(6):649-657. PubMed ID: 27646493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.